. 2022 Oct 10;13:1023635. doi: 10.3389/fendo.2022.1023635

Table 1.

Clinical characteristics, hormonal profile and reproductive outcomes of infertile women according to TSH levels.

Variables*	TSH levels				p-value
Variables*	≥0.5 ≤ 2.49 mUI/mL		≥2.5 ≤ 4.5 mUI/mL		p-value
N	211	82.4	45	17.6	–
Age (years)	34	[32-37]	34	[32-37]	0.431^a
BMI (Kg/m2)	22.7	[21.2-25]	22.6	[21.3-24.6]	0.489 ^a
FSH (mUI/mL)	6.5	[5.3-7.4]	6.4	[5.5-7.4]	0.439 ^a
LH (mUI/mL)	5.6	[4.1-6.9]	5	[3.9-7.7]	0.429 ^a
FT4 (ng/dL)	1.1	[1-1.2]	1.1	[1-1.2]	0.473 ^a
25(OH)D (ng/mL)	30	[23-40.2]	32.2	[25.4-42.1]	0.145 ^a
Prolactin (ng/mL)	12.5	[8.6-17.4]	12.5	[9.4-16.9]	0.421^a
AFC	13	[9-19]	14	[9-19]	0.322 ^a
Total FSHr (UI)	2025	[1575-2400]	1800	[1575-2100]	0.369 ^a
Oocytes retrieved	10	[6-15]	9	[6-13]	0.177 ^a
MII	8	[5-12]	7	[5-11]	0.157 ^a
Embryos	4	[3-6]	4	[3-6]	0.319 ^a
Clinical Pregancy rate (n, %)	97	45.9	20	44.4	0.982^b
Live-births (n)	121	57.3	23	51.1	0.225^b
Twins (n, %)	27	27.8	3	15.0	0.365^b
Pre-term (n, %)	13	13.4	3	15.0	0.99^b

*Qualitative variables were presented by absolute and relative frequency, and quantitative variables by median and interquartil interval. 25(OH)D; 25-Hydroxyvitamin D, AFC; Antral Follicle Count, BMI; Body Mass Index: FSH; Follicle-stimulating hormone, FSHr; Recombinant FSH, FT4; free Thyroxine, LH; Luteinizing hormone, MII; Metaphase II oocytes, TSH; Thyroid stimulating hormone. aMann-Whitney U test, bChi-Square test.